NCT06824714View on ClinicalTrials.gov

Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2028

Study Completion Date

July 1, 2028

Conditions
Large Vessel Vasculitis
Interventions
DRUG

glucocorticoid, immunosuppressants, targeted therapy

Drug intervention protocol will be determined by clinicians

Trial Locations (1)

210029

RECRUITING

Department of Rheumatology and Immunology, Jiangsu Province Hospital, Nanjing Medical University, Nanjing

Sponsors
All Listed Sponsors
lead

Nanjing Medical University

OTHER

NCT06824714 - Prediction of Risk of Vascular Structural Damage in Patients With Large Vessel Vasculitis (LVV) Based on PET/MRA Image Evaluation System | Biotech Hunter | Biotech Hunter